Medtronic plc — Director's Dealing 2017

Sep 19, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2017-09-15

Reporting Person: ISHRAK OMAR (Director, Chairman & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-09-15	Ordinary Shares	M	100000	$38.81	Acquired	668503	Direct
2017-09-15	Ordinary Shares	S	140407	$81.63	Disposed	528096	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-09-15	Stock Option (Right to Buy)	$38.81	M	100000	Disposed	2022-07-30	Ordinary Shares (100000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	12195	Indirect

Footnotes

F1: The exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $81.464 to $81.941, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F3: This option to purchase 290,338 New Medtronic ordinary shares for $38.81 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 290,338 Medtronic common stock shares for $38.81 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.